Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anus Neoplasms × Immune Checkpoint Inhibitors × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 15 Carcinoma, Hepatocellular 9 Recurrence 5 Neoplasm Metastasis 5 Nasopharyngeal Carcinoma 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Stomach Neoplasms 4 Melanoma 4 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Small Cell Lung Carcinoma 2 Rectal Neoplasms 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myeloid, Acute 2 Hyperthermia 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Biliary Tract Neoplasms 2 Advanced Refractory Solid Tumors 2 Advanced NSCLC 2

Interventions

Fluorouracil 11 Cisplatin 6 Capecitabine 5 pembrolizumab 4 dehydroftorafur 4 Specimen Handling 4 Radiotherapy 4 Radiation 4 Mitomycin 4 Paclitaxel 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Drug Therapy 3 Cetuximab 3 Carboplatin 3 Biopsy 3 Radiotherapy, Intensity-Modulated 2 Platinum 2 Mitozytrex 2 Fluorodeoxyglucose F18 2 1,2-diaminocyclohexaneplatinum II citrate 2 toripalimab 1 tislelizumab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 durvalumab 1 avelumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04230759 2024-09-19

RADIANCE

Goethe University

Phase 2 Active not recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡